Pancreatic cystic neoplasms: Still high rates of preoperative misdiagnosis in the guidelines and endoscopic ultrasound era

• Published in: Surgery 2023-12, Vol.174 (6), p.1410-1415
• Main Authors: Salvia, Roberto, Burelli, Anna, Nepi, Angelica, Caravati, Andrea, Tomelleri, Claudia, Dall’Olio, Tommaso, Casciani, Fabio, Crinò, Stefano Francesco, Perri, Giampaolo, Marchegiani, Giovanni
• Format: Article
• Language: English
• Subjects: Diagnostic Errors; Endosonography; Humans; Neoplasms, Cystic, Mucinous, and Serous; Pancreas; Pancreatic Neoplasms - diagnostic imaging; Pancreatic Neoplasms - surgery
• ISSN: 0039-6060; 1532-7361
• DOI: 10.1016/j.surg.2023.07.016

A wrong diagnosis of nature is common in pancreatic cystic neoplasms. The aim of the current study is to reappraise the diagnostic errors for presumed pancreatic cystic neoplasms in patients undergoing surgery. All pancreatic resections for presumed pancreatic cystic neoplasms following international guidelines between 2011 and 2020 were analyzed. Misdiagnosis was defined as the discrepancy between preoperative diagnosis of nature and final pathology. Mismatch was defined as the discrepancy between the preoperative suspect of malignancy (or its absence) and final pathology. A total of 601 patients were included. Endoscopic ultrasound was performed in 301 (50%) patients. Overall misdiagnosis and mismatch were 19% and 34%, respectively, with no significant benefit for those patients who underwent endoscopic ultrasound. The highest rate of misdiagnosis was reached for cystic neuroendocrine tumors (61%) and the lowest for solid pseudopapillary tumors (6%). Several diagnostic errors had clinical relevance, including 7 (13%) presumed serous cystic neoplasms eventually found to be other malignant entities, 50 (24%) intraductal papillary mucinous neoplasms with high-risk stigmata revealed to be non-malignant, and 38 (33%) intraductal papillary mucinous neoplasms without high-risk stigmata revealed to be malignant at final pathology. A preoperative presumption of malignant mucinous cystic neoplasm was correct in only 20 (16%) patients. Despite not always being clinically relevant, diagnostic errors are still common among resected pancreatic cystic neoplasms when applying international guidelines. New diagnostic tools beyond endoscopic ultrasound are needed to refine the diagnosis of those lesions at higher risk for unnecessary surgery or accidentally observed, nevertheless being malignant.